Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Higher IGF-1 levels in hair follicles link to better finasteride results for hair loss.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Plant compounds may offer a promising alternative for cancer treatment.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Iron deficiency is not a significant cause of hair loss in women.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Suppressing certain hormones might help prevent prostate cancer.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Early treatment of acne is important to prevent scarring and improve appearance, using medications that can have side effects.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Balding and low testosterone increase risk of urinary stones.

Hair loss can be reversed or even cured using advanced hair restoration techniques, with rare complications like swelling and bleeding.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.